Loss of Chromosome 13 is the Most Frequent Genomic Imbalance in Malignant Fibrous Histiocytomas
- 1 June 1999
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 111 (2) , 134-138
- https://doi.org/10.1016/s0165-4608(98)00227-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 19p + marker chromosome correlates with relapse in malignant fibrous histiocytomaGenes, Chromosomes and Cancer, 1996
- MDM2 Amplification, P53 Mutation, and Accumulation of the P53 Gene Product in Malignant Fibrous HistiocytomaDiagnostic Molecular Pathology, 1996
- A cytogenetic study of malignant fibrous histiocytomaCancer Genetics and Cytogenetics, 1995
- Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21–q22 in soft tissue sarcomasGenes, Chromosomes and Cancer, 1995
- Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumorsGenes, Chromosomes and Cancer, 1994
- Amplification of the c-myc Proto-Oncogene in Soft Tissue SarcomasOncology, 1994
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992
- Analysis of Alterations in the Retinoblastoma Gene and Tumor Grade in Bone and Soft-Tissue SarcomasJNCI Journal of the National Cancer Institute, 1991
- Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rateGenes, Chromosomes and Cancer, 1990
- Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytomaGenes, Chromosomes and Cancer, 1989